Tempus AI (NASDAQ:TEM) delivered a very mixed Q4 2024 earnings report that saw its shares sell off about 15% after hours. The main takeaway here is that Tempus' core business is expected to grow ...

JPMorgan downgraded Tempus AI (TEM) to Neutral from Overweight with a price target of $55, up from $50. The company reported Q4 results in-line with the preannouncement and its 2025 guidance ...

Google Agreement: Extended for another five years. Tempus AI Inc (NASDAQ:TEM) reported a 35.8% year-over-year revenue growth in Q4 2024, with gross profit growth accelerating to 49.7%. The company ...

Please go ahead. Thank you, Jason. Good afternoon and welcome to Tempus' Fourth Quarter 2024 Conference Call. This afternoon Tempus released results for the quarter and year ended December 31 ...

Tempus is expected to releases its 2024 fiscal-year fourth-quarter earnings report after the market closes. Analysts estimate a loss per share of 20 cents and revenue of $203.12 million. Get 5 ...

These speculations have surged in the past month after her investment in AI healthcare firm Tempus AI (NASDAQ:TEM) surged over 300% since 14th January. According to the latest periodic transaction ...

Just a few weeks ago, Tempus AI (NASDAQ: TEM) rocketed from about 44% higher. All on news it just acquired Ambry Genetics, a well-known leader in genetic testing, for $600 million, which included ...

Kristin Jenn was a seasonal park ranger for Denali National Park for two seasons before accepting a permanent position at another park. Shortly after, she was given a letter saying management ...

Hanna Porter hit a walk-off grand slam to lift Newbury Park to a 7-4 win over Chaminade in a season opener. Nikki Kennedy went 1 for 2 with a double and an RBI, Yasmin Topinko was 1 for 3 with an ...

Tempus AI has raised an additional $300 million in incremental debt financing from alternative investment manager Ares Management that is intended to support the firm's recent acquisition of Ambry ...